[go: up one dir, main page]

EE05259B1 - Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks - Google Patents

Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks

Info

Publication number
EE05259B1
EE05259B1 EEP200300155A EEP200300155A EE05259B1 EE 05259 B1 EE05259 B1 EE 05259B1 EE P200300155 A EEP200300155 A EE P200300155A EE P200300155 A EEP200300155 A EE P200300155A EE 05259 B1 EE05259 B1 EE 05259B1
Authority
EE
Estonia
Prior art keywords
antiprogestins
prophylaxis
treatment
dependent diseases
hormone dependent
Prior art date
Application number
EEP200300155A
Other languages
English (en)
Inventor
Hoffmann Jens
Lichtner Rosemarie
Siemeister Gerd
Schneider Martin
Fuhrmann Ulrike
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200300155A publication Critical patent/EE200300155A/et
Publication of EE05259B1 publication Critical patent/EE05259B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200300155A 2000-10-18 2001-10-17 Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks EE05259B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24099800P 2000-10-18 2000-10-18
EP00250341 2000-10-18
PCT/EP2001/012005 WO2002032430A1 (en) 2000-10-18 2001-10-17 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases

Publications (2)

Publication Number Publication Date
EE200300155A EE200300155A (et) 2003-08-15
EE05259B1 true EE05259B1 (et) 2010-02-15

Family

ID=26072951

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300155A EE05259B1 (et) 2000-10-18 2001-10-17 Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks

Country Status (26)

Country Link
US (1) US7378406B2 (et)
EP (1) EP1328276B1 (et)
JP (2) JP2004511522A (et)
KR (1) KR100632908B1 (et)
CN (1) CN1512886A (et)
AT (1) ATE310522T1 (et)
AU (2) AU2002218243B2 (et)
BG (1) BG107743A (et)
BR (1) BR0114665A (et)
CA (1) CA2423017C (et)
CY (1) CY1104981T1 (et)
CZ (1) CZ299942B6 (et)
DE (1) DE60115274T2 (et)
DK (1) DK1328276T3 (et)
EE (1) EE05259B1 (et)
ES (1) ES2253443T3 (et)
HR (1) HRP20030387A2 (et)
HU (1) HUP0301460A3 (et)
IL (2) IL154975A0 (et)
MX (1) MXPA03002954A (et)
NO (1) NO20031740L (et)
NZ (1) NZ538346A (et)
PL (1) PL360151A1 (et)
SI (1) SI1328276T1 (et)
SK (1) SK287124B6 (et)
WO (1) WO2002032430A1 (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
US9517240B2 (en) * 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20080268041A1 (en) * 2007-04-23 2008-10-30 Jens Hoffmann Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
US20080261929A1 (en) * 2007-04-23 2008-10-23 Jens Hoffmann Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
US20090029954A1 (en) * 2007-04-23 2009-01-29 Jens Hoffmann Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
TWI539953B (zh) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
EP2550288A1 (en) * 2010-03-22 2013-01-30 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
MX363640B (es) 2012-05-31 2019-03-28 Repros Therapeutics Inc Formulaciones y metodos para la administracion vaginal de antiprogestinas.
WO2014070517A1 (en) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

Also Published As

Publication number Publication date
EE200300155A (et) 2003-08-15
HRP20030387A2 (en) 2005-04-30
HUP0301460A2 (hu) 2003-10-28
EP1328276B1 (en) 2005-11-23
CA2423017A1 (en) 2002-04-25
JP2004511522A (ja) 2004-04-15
CA2423017C (en) 2009-01-06
AU2002218243B2 (en) 2006-07-13
KR100632908B1 (ko) 2006-10-13
DE60115274T2 (de) 2006-07-27
NO20031740L (no) 2003-06-17
JP2010077158A (ja) 2010-04-08
KR20030044007A (ko) 2003-06-02
CY1104981T1 (el) 2010-03-03
US20040048841A1 (en) 2004-03-11
PL360151A1 (en) 2004-09-06
IL154975A (en) 2007-05-15
BG107743A (bg) 2004-01-30
MXPA03002954A (es) 2003-08-07
IL154975A0 (en) 2003-10-31
BR0114665A (pt) 2004-01-13
NZ538346A (en) 2007-03-30
ES2253443T3 (es) 2006-06-01
CZ299942B6 (cs) 2008-12-29
DK1328276T3 (da) 2006-04-03
EP1328276A1 (en) 2003-07-23
SK287124B6 (sk) 2009-12-07
SK4742003A3 (en) 2004-09-08
US7378406B2 (en) 2008-05-27
SI1328276T1 (sl) 2006-04-30
NO20031740D0 (no) 2003-04-15
WO2002032430A1 (en) 2002-04-25
ATE310522T1 (de) 2005-12-15
DE60115274D1 (de) 2005-12-29
HUP0301460A3 (en) 2010-01-28
AU1824302A (en) 2002-04-29
CN1512886A (zh) 2004-07-14

Similar Documents

Publication Publication Date Title
EE05259B1 (et) Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks
EA200201000A1 (ru) Гормон-заместительная терапия
MA26843A1 (fr) NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE
KR970704451A (ko) 기능부전성 자궁출혈 치료용 약제의 제조에 유용한 프로게스테론 길항제(Progesterone Antagonists Useful for Preparing Medicaments for Treating Dysfunctional Uterine Bleeding)
EA200301022A1 (ru) Гормональная заместительная терапия
NO20025157L (no) Kreftterapi
MXPA05012841A (es) Composicion que comprende antagonistas de receptores de progesterona y antiestrogenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas.
YU30103A (sh) Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti
EE200300157A (et) Antiprogestiinide kasutamine apoptoosi esilekutsumiseks rakus
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
YU29903A (sh) Upotreba antiprogestina za indukciju apoptoze u ćeliji
UY27301A1 (es) Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20101017